Skip to main content
. 2008 Jun 20;23(3):439–444. doi: 10.3346/jkms.2008.23.3.439

Table 4.

Treatment outcomes

graphic file with name jkms-23-439-i004.jpg

Death d/t Ds progression.

CTx, chemotherapy; wk, week; Tx, treatment; OS, overall survival; CR, complete response; PR, partial response; NR, no response; DHAP, dexamethasone, cytarabine and cisplatin; NE, not evaluable; AlloSCT, allogeneic stem cell transplantation; d/t, due to; Ds, disease; F/U, follow-up; EBV, Epstein-Barr virus; ESHAP, etoposide, methylprednisolone, high-dose cytarabine and cisplatin.